[KSIC 1] |
Apr. 19 (Fri.) 14:30-16:00 104 (1F) |
Essence of Interventional Cardiology 2018 |
Chairperson(s) | 안태훈, 정명호 |
Panel | 송영빈, 윤경호, 이상록, 이장훈, 임성훈, 정영훈, 한주용 |
14:30-14:45 |
Is Percutaneous Repair of Secondary Mitral Regurgitation Effective?
|
강시혁 / 서울의대 |
14:45-15:00 |
PCI Plus Medical Therapy Versus Medical Therapy Alone in Stable Coronary Artery Disease: Update from Recent Trials
|
박덕우 / 울산의대 |
15:00-15:15 |
Guide My Clinical Practice: 2018 Update of Clinical Outcomes in Currently Available 2nd Generation DES in Korea
|
김민철 / 전남의대 |
15:15-15:30 |
Are Paclitaxel Coated Devices Safe in Peripheral Artery Disease Intervention?
|
노재형 / 충남의대 |
15:30-16:00 |
Discussion |
[KSIC 2] |
Apr. 19 (Fri.) 16:10-17:40 104 (1F) |
Disaster and Safety: How to Handle in the Cath. Lab. |
Chairperson(s) | 장양수, 김효수 |
Panel | 김원, 이왕수, 조상호, 최성훈, 최윤석, 최철웅, 홍순준 |
16:10-16:22 |
Acute Vessel Closure: Now What?
|
김웅 / 영남의대 |
16:22-16:34 |
How to Treat Coronary Perforation
|
원호연 / 중앙의대 |
16:34-16:46 |
Stent Is Gone: Equipment Loss and/or Entrapment
|
이진배 / 대구가톨릭의대 |
16:46-16:58 |
How to Prevent Contrast Injury
|
김제상 / 세종병원 |
16:58-17:10 |
How to Prevent Radiation Injury for Patients&Staffs
|
이상엽 / 충북의대 |
17:10-17:40 |
Discussion |
[KSIC 3] |
Apr. 20 (Sat.) 09:00-10:30 104 (1F) |
Vascular Access: A To Z |
Chairperson(s) | 한규록, 김두일 |
Panel | 강태수, 김상민, 도준형, 윤창환, 이봉기, 이장훈, 전국진 |
09:00-09:12 |
Vascular Access for Coronary Intervention - TFI, TRI, Distal Radial
|
이준원 / 연세원주의대 |
09:12-09:24 |
Vascular Access for Non-Coronary Intervention - TFI, TRI, Brachial, Others
|
고충원 / 한림의대 |
09:24-09:36 |
Hemostasis: A to Z
|
허정호 / 고신의대 |
09:36-09:48 |
How to Solve Access Site Problems
|
유상용 / 울산의대 |
09:48-10:00 |
Tips & Tricks of Vascular Access
|
이재환 / 충남의대 |
10:00-10:30 |
Discussion |
[KSIC 4] |
Apr. 20 (Sat.) 13:10-14:40 104 (1F) |
Debates in Medical Treatments Other than Antithrombotic Treatment after PCI |
Chairperson(s) | 윤정한, 채인호 |
Panel | 김원, 김중선, 남창욱, 양태현, 우종신, 홍영준 |
13:10-13:22 |
Statin: High Dose Statin vs. Ezetimibe Combination?
|
김병극 / 연세의대 |
13:22-13:34 |
Beta Blocker after AMI: How Much, How Long, Which Drug, and in Which Patients?
|
박진주 / 서울의대 |
13:34-13:46 |
RAS Inhibitors: In Every Patients or Only in Hypertensive Patients?
|
박근호 / 조선의대 |
13:46-13:58 |
Antihyperglycemic Agents: Which Drugs and How Intensive?
|
정영훈 / 경상의대 |
13:58-14:10 |
Antianginal Medications: Which Drugs and in Which Patients?
|
배장환 / 충북의대 |
14:10-14:40 |
Discussion |
[KSIC 5-1] |
Apr. 20 (Sat.) 14:50-15:35 104 (1F) |
Debate in Interventional Cardiology |
Chairperson(s) | 김종진, 박창규 |
Panel | 강웅철, 김주한, 김학령, 이병권, 이왕수, 조진만, 최철웅 |
|
Renal Denervation in Resistant Hypertension: Something, Nothing Or Everything?! |
14:50-15:05 |
Pros
|
최승혁 / 성균관의대 |
15:05-15:20 |
Cons
|
신진호 / 한양의대 |
15:20-15:35 |
Discussion |
[KSIC 5-2] |
Apr. 20 (Sat.) 15:35-16:20 104 (1F) |
Debate in Interventional Cardiology |
Chairperson(s) | 홍명기, 장병철 |
Panel | 공준혁, 김준범, 김준홍, 나승운, 박근호, 장기육 |
|
TAVR in Low Risk Patient: Light on the Horizon? |
15:35-15:50 |
Interventionist's View
|
고영국 / 연세의대 |
15:50-16:05 |
Surgeon's View
|
황호영 / 서울의대 |
16:05-16:20 |
Discussion |